Martin Falke

Martin Falke has extensive work experience in the pharmaceutical industry. Martin served as the Head of Quality Control Microbiology at Vetter Pharma from October 2019 onwards. Prior to that, they were the Team Manager for Pharmaceutical Production at the same company from November 2016 to October 2019.

Before joining Vetter Pharma, Martin worked as a PhD Student at ETH Zurich from July 2012 to August 2016. Martin also gained experience as a Master Student at dkfz - German Cancer Research Center from September 2011 to April 2012, Roche Diagnostic Corp from May 2011 to August 2011, and the National Cancer Institute (NCI) from August 2010 to January 2011.

Martin Falke attended Universität Rostock from 2006 to 2009, where they obtained a Bachelor's Degree in Medical Biotechnology. Martin then pursued a Master of Science (M.S.) in Molecular Bioscience at Heidelberg University from 2009 to 2012. Following this, they continued their education at ETH Zürich from 2012 to 2016, earning a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology.